{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:11:56Z","timestamp":1791317516909,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.addbeh.2022.107343","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T01:55:06Z","timestamp":1651110906000},"page":"107343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults"],"prefix":"10.1016","volume":"132","author":[{"given":"Kevin H.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2022.107343_b0005","unstructured":"American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.) (DSM-IV). Washington DC: American Psychiatric Association."},{"issue":"11","key":"10.1016\/j.addbeh.2022.107343_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5100","article-title":"Suicidal cut-throat wound during LSD intoxication","volume":"9","author":"Bose","year":"2021","journal-title":"Clinical Case Reports"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107343_b0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0897190014566314","article-title":"Hallucinogen Persisting Perception Disorder and Risk of Suicide","volume":"29","author":"Brodrick","year":"2016","journal-title":"Journal of Pharmacy Practice"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107343_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2045125316689030","article-title":"Ayahuasca, dimethyltryptamine, and psychosis: A systematic review of human studies","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"6","key":"10.1016\/j.addbeh.2022.107343_b0025","first-page":"6","article-title":"A Closer Look at Substance Use and Suicide","volume":"13","author":"Esang","year":"2018","journal-title":"American Journal of Psychiatry Residents\u2019 Journal"},{"key":"10.1016\/j.addbeh.2022.107343_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103612","article-title":"Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees","volume":"102","author":"Grabski","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.addbeh.2022.107343_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.abrep.2019.100228","article-title":"Hallucinogen Use is Associated with Mental Health and Addictive Problems and Impulsivity in University Students","volume":"10","author":"Grant","year":"2019","journal-title":"Addictive Behaviors Reports"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107343_b0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107343_b0045","series-title":"Handbook of medical hallucinogens","year":"2021"},{"key":"10.1016\/j.addbeh.2022.107343_b0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-Assisted Psychotherapy in Patients with Terminal Cancer","volume":"8","author":"Grof","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107343_b0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107343_b0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2018.01.049","article-title":"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans","volume":"142","author":"Heal","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addbeh.2022.107343_b0065","unstructured":"Hedden, S., Gfroerer, J., Barker, P., Smith, S., Pemberton, M. R., Saavedra, L. M., Forman-Hoffman, V. L., Ringeisen, H., & Novak, S. P. (2012). Comparison of NSDUH Mental Health Data and Methods with Other Data Sources. In CBHSQ Data Review. Substance Abuse and Mental Health Services Administration (US). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK390286\/."},{"issue":"9","key":"10.1016\/j.addbeh.2022.107343_b0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0269881115598338","article-title":"Psilocybin, psychological distress, and suicidality","volume":"29","author":"Hendricks","year":"2015","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107343_b0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107343_b0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: A population study","volume":"29","author":"Johansen","year":"2015","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107343_b0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/02698811211066714","article-title":"Lifetime use of MDMA\/ecstasy and psilocybin is associated with reduced odds of major depressive episodes","volume":"36","author":"Jones","year":"2022","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.addbeh.2022.107343_b0090","article-title":"MDMA\/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults","volume":"02698811211058923","author":"Jones","year":"2022","journal-title":"Journal of Psychopharmacology"},{"issue":"S1","key":"10.1016\/j.addbeh.2022.107343_b0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mpr.310","article-title":"Screening for serious mental illness in the general population with the K6 screening scale: Results from the WHO World Mental Health (WMH) survey initiative","volume":"19","author":"Kessler","year":"2010","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"10.1016\/j.addbeh.2022.107343_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108715","article-title":"LSD use in the United States: Trends, correlates, and a typology of us","volume":"223","author":"Killion","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.addbeh.2022.107343_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and Mental Health: A Population Study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.addbeh.2022.107343_b0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0957154X16629902","article-title":"Neurotoxicity and LSD treatment: A follow-up study of 151 patients in Denmark","volume":"27","author":"Larsen","year":"2016","journal-title":"History of Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107343_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Microdosing psychedelics: Motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.addbeh.2022.107343_b0120","unstructured":"Lipari, R. N., Hedden, S. L., & Hughes, A. (2013). Substance Use and Mental Health Estimates from the 2013 National Survey on Drug Use and Health: Overview of Findings. In The CBHSQ Report. Substance Abuse and Mental Health Services Administration (US). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385055\/."},{"issue":"3","key":"10.1016\/j.addbeh.2022.107343_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/026988110101500310","article-title":"Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms","volume":"15","author":"MacInnes","year":"2001","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2022.107343_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/appy.12225","article-title":"Salvia divinorum: An overview of the usage, misuse, and addiction processes","volume":"8","author":"Mahendran","year":"2016","journal-title":"Asia-Pacific Psychiatry: Official Journal of the Pacific Rim College of Psychiatrists"},{"key":"10.1016\/j.addbeh.2022.107343_b0135","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3389\/fpsyt.2021.780696","article-title":"Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes","volume":"12","author":"Matzopoulos","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107343_b0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00213-004-1791-0","article-title":"Chronic MDMA (ecstasy) use, cognition and mood","volume":"173","author":"McCardle","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107343_b0145","doi-asserted-by":"crossref","unstructured":"Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot\u2019alora G., M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., \u2026 Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025\u20131033. 10.1038\/s41591-021-01336-3.","DOI":"10.1038\/s41591-021-01336-3"},{"issue":"10","key":"10.1016\/j.addbeh.2022.107343_b0150","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"The American Journal of Psychiatry"},{"issue":"16","key":"10.1016\/j.addbeh.2022.107343_b0155","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychological Medicine"},{"issue":"9","key":"10.1016\/j.addbeh.2022.107343_b0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0269881115596156","article-title":"The link between use of psychedelic drugs and mental health problems","volume":"29","author":"Nesv\u00e5g","year":"2015","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.addbeh.2022.107343_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/ajad.13259","article-title":"Ketamine use in relation to depressive symptoms among high school seniors","author":"Palamar","year":"2022","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2022.107343_b0170","first-page":"1","article-title":"Media coverage about medical benefits of MDMA and ketamine affects perceived likelihood of engaging in recreational use","author":"Palamar","year":"2021","journal-title":"Addiction Research & Theory"},{"issue":"4","key":"10.1016\/j.addbeh.2022.107343_b0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychological Medicine"},{"issue":"13","key":"10.1016\/j.addbeh.2022.107343_b0180","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1017\/S0033291719002393","article-title":"LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making","volume":"50","author":"Pokorny","year":"2020","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.addbeh.2022.107343_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109139","article-title":"Toward a typology of hallucinogen users in the United States","volume":"229","author":"Salas-Wright","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2022.107343_b0190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fpsyt.2019.00896","article-title":"Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics","volume":"10","author":"Sexton","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.addbeh.2022.107343_b0195","unstructured":"Substance Abuse and Mental Health Services Administration. (2020). Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. 156."},{"issue":"8","key":"10.1016\/j.addbeh.2022.107343_b0200","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1017\/S0033291717002781","article-title":"Trends in depression prevalence in the USA from 2005 to 2015: Widening disparities in vulnerable groups","volume":"48","author":"Weinberger","year":"2018","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1016\/j.addbeh.2022.107343_b0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1556\/2054.2019.014","article-title":"\u201cGo ask Alice, when she\u2019s 10-feet tall\u201d: Psychosocial correlates to lifetime LSD use among a national sample of US adults","volume":"3","author":"Yockey","year":"2019","journal-title":"Journal of Psychedelic Studies"},{"key":"10.1016\/j.addbeh.2022.107343_b0210","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Frontiers in Pharmacology"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460322001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460322001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:48:22Z","timestamp":1759690102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460322001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"alternative-id":["S0306460322001095"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2022.107343","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2022.107343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107343"}}